{"id":6866,"date":"2023-05-25T01:08:40","date_gmt":"2023-05-25T01:08:40","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6866"},"modified":"2023-08-29T17:58:01","modified_gmt":"2023-08-29T17:58:01","slug":"immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6866","title":{"rendered":"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f"},"content":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002<\/p>\n<p>AIPAC-003\u6b63\u5728\u8bc4\u4f30\u8be5\u516c\u53f8\u7684\u53ef\u6eb6\u6027LAG-3\u86cb\u767d\u548c\u88ab\u79f0\u4e3aefilagimod alpha\uff08efti\uff09\u7684\u7b2c\u4e00\u7c7bMHC II\u7c7b\u6fc0\u52a8\u5242\u4e0e\u6807\u51c6\u62a4\u7406\u7684\u7d2b\u6749\u9187\u8054\u5408\u6cbb\u7597\u8f6c\u79fb\u6027HER2\u9634\u6027\/\u4f4e\u5ea6\u4e73\u817a\u764c\u548c\u4e09\u9634\u6027\u4e73\u817a\u764c\u3002<\/p>\n<p>\u8fd9\u9879\u5f00\u653e\u6807\u7b7e\u8bd5\u9a8c\u5c06\u5728\u6b27\u6d32\u548c\u7f8e\u56fd\u768417\u4e2a\u5730\u70b9\u8fdb\u884c\uff0c\u60a3\u8005\u5c06\u5728\u540c\u4e00\u5929\u63a5\u53d7efti\u548c\u7d2b\u6749\u9187\u7684\u6cbb\u7597\uff0c\u5e76\u6301\u7eed\u5230\u75be\u75c5\u8fdb\u5c55\u3002<\/p>\n<p>\u8bd5\u9a8c\u7684\u524d\u5bfc\u9636\u6bb5\u5c06\u6709\u591a\u8fbe12\u540d\u60a3\u8005\u63a5\u53d790\u6beb\u514befti\u7684\u6cbb\u7597\uff0c\u968f\u540e\u7b2c\u4e8c\u9636\u6bb5\u7684\u968f\u673a\uff081:1\uff09\u90e8\u5206\u7531\u591a\u8fbe58\u540d\u60a3\u8005\u7ec4\u6210\uff0c\u4ed6\u4eec\u5c06\u63a5\u53d730\u6beb\u514befti\u621690\u6beb\u514befti\uff0c\u4ee5\u786e\u5b9a\u4e0e\u7d2b\u6749\u9187\u8054\u5408\u4f7f\u7528\u7684\u6700\u4f73\u751f\u7269\u5242\u91cf\u3002<\/p>\n<p>\u968f\u540e\u53ef\u80fd\u8fdb\u884c\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u7684III\u671f\u6cbb\u7597\uff08\u7b49\u5f85II\u671f\u6cbb\u7597\u7ed3\u679c\uff09\uff0c\u603b\u4f53\u751f\u5b58\u7387\u5c06\u662f\u4e3b\u8981\u76ee\u6807\u3002<\/p>\n<p>Immutep\u4e4b\u524d\u7684efti\u8bd5\u9a8c\u663e\u793a\u4e86\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u7ed3\u679c\uff0c\u5305\u62ec2.9\u4e2a\u6708\u7684\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\uff0c\u4ee5\u53ca\u5728\u9884\u5148\u6307\u5b9a\u7684\u4e9a\u7ec4\u4e2d\uff0c4.2\u81f319.6\u4e2a\u6708\u7684\u663e\u8457\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\u6539\u5584\u3002<\/p>\n<h2>\u91cc\u7a0b\u7891\u5f0f\u53d1\u5c55<\/h2>\n<p>Immutep\u516c\u53f8\u9996\u5e2d\u79d1\u5b66\u5b98Fr\u00e9d\u00e9ric Triebel\u6559\u6388\u8bf4\uff0c\u7b2c\u4e00\u4e2a\u75c5\u4eba\u7684\u5242\u91cf\u88ab\u8ba4\u4e3a\u662f\u8be5\u516c\u53f8\u7684\u4e00\u4e2a\u91cc\u7a0b\u7891\u5f0f\u7684\u53d1\u5c55\u3002<\/p>\n<p>&#8220;\u4ed6\u8bf4\uff1a&#8221;\u6211\u4eec\u7684\u76ee\u6807\u662f\u6539\u5584\u4e34\u5e8a\u7ed3\u679c\uff0c\u91cd\u70b9\u662f\u5728\u7b2c\u4e09\u9636\u6bb5\u4e3a\u63a5\u53d7\u6807\u51c6\u62a4\u7406\u5316\u7597\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u4e2a\u5f3a\u6709\u529b\u7684\u4e3b\u8981\u7ec8\u70b9\uff0c\u5373\u603b\u751f\u5b58\u671f\u3002<\/p>\n<p>&#8220;\u6211\u4eec\u671f\u5f85\u7740\u770b\u523090\u6beb\u514b\u7684efti\u5242\u91cf\u4e0e\u540c\u65e5\u7ed9\u836f\u7684efti\u52a0\u7d2b\u6749\u9187\uff0c\u76f4\u5230\u75be\u75c5\u8fdb\u5c55\uff0c\u53ef\u80fd\u4f1a\u5efa\u7acb\u5728\u6211\u4eec\u4ee5\u524d\u7684\u8bd5\u9a8c\u7ed3\u679c\u4e4b\u4e0a\u3002&#8221;<\/p>\n<h2>\u764c\u75c7\u7684\u6cbb\u7597<\/h2>\n<p>Efti\u662fImmutep\u516c\u53f8\u4e13\u6709\u7684\u53ef\u6eb6\u6027LAG-3\u86cb\u767d\u548cMHC II\u7c7b\u6fc0\u52a8\u5242\uff0c\u53ef\u523a\u6fc0\u5148\u5929\u548c\u9002\u5e94\u6027\u514d\u75ab\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u3002<\/p>\n<p>\u4f5c\u4e3a\u4e00\u6d41\u7684\u6297\u539f\u5448\u9012\u7ec6\u80de\uff08APC\uff09\u6fc0\u6d3b\u5242\uff0cEfti\u4e0eMHC\uff08\u4e3b\u8981\u7ec4\u7ec7\u76f8\u5bb9\u6027\u590d\u5408\u4f53\uff09II\u7c7b\u5206\u5b50\u7ed3\u5408\uff0c\u5bfc\u81f4CD8+\u7ec6\u80de\u6bd2\u6027T\u6dcb\u5df4\u7ec6\u80de\u3001CD4+\u8f85\u52a9T\u7ec6\u80de\u3001\u6811\u7a81\u72b6\u7ec6\u80de\u3001\u81ea\u7136\u6740\u4f24\uff08NK\uff09\u7ec6\u80de\u548c\u5355\u6838\u7ec6\u80de\u7684\u6fc0\u6d3b\u548c\u589e\u751f\u3002<\/p>\n<p>\u5b83\u8fd8\u80fd\u4e0a\u8c03\u5173\u952e\u751f\u7269\u5206\u5b50\u7684\u8868\u8fbe\uff0c\u5982IFN-y\uff08\u5e72\u6270\u7d20\u03b3\uff09\u548cCXCL10\uff0c\u8fdb\u4e00\u6b65\u63d0\u9ad8\u514d\u75ab\u7cfb\u7edf\u7684\u6297\u764c\u80fd\u529b\u3002<\/p>\n<p>Efti\u6b63\u88ab\u8bc4\u4f30\u7528\u4e8e\u5404\u79cd\u5b9e\u4f53\u80bf\u7624\uff0c\u5305\u62ec\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u3001\u5934\u9888\u90e8\u9cde\u72b6\u7ec6\u80de\u764c\uff08HNSCC\uff09\u548c\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u3002<\/p>\n<p>\u5b83\u66fe\u5728\u4e00\u7ebfHNSCC\u548c\u4e00\u7ebfNSCLC\u4e2d\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u5feb\u901f\u901a\u9053\u6307\u5b9a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002 AIPAC-003\u6b63\u5728\u8bc4\u4f30\u8be5\u516c\u53f8\u7684\u53ef\u6eb6\u6027LAG-3\u86cb\u767d\u548c\u88ab\u79f0\u4e3aefilagimod alpha\uff08efti\uff09\u7684\u7b2c\u4e00\u7c7bMHC II\u7c7b\u6fc0\u52a8\u5242\u4e0e\u6807\u51c6\u62a4\u7406\u7684\u7d2b\u6749\u9187\u8054\u5408\u6cbb\u7597\u8f6c\u79fb\u6027HER2\u9634\u6027\/\u4f4e\u5ea6\u4e73\u817a\u764c\u548c\u4e09\u9634\u6027\u4e73\u817a\u764c\u3002 \u8fd9\u9879\u5f00\u653e\u6807\u7b7e\u8bd5\u9a8c\u5c06\u5728\u6b27\u6d32\u548c\u7f8e\u56fd\u768417\u4e2a\u5730\u70b9\u8fdb\u884c\uff0c\u60a3\u8005\u5c06\u5728\u540c\u4e00\u5929\u63a5\u53d7efti\u548c\u7d2b\u6749\u9187\u7684\u6cbb\u7597\uff0c\u5e76\u6301\u7eed\u5230\u75be\u75c5\u8fdb\u5c55\u3002 \u8bd5\u9a8c\u7684\u524d\u5bfc\u9636\u6bb5\u5c06\u6709\u591a\u8fbe12\u540d\u60a3\u8005\u63a5\u53d790\u6beb\u514befti\u7684\u6cbb\u7597\uff0c\u968f\u540e\u7b2c\u4e8c\u9636\u6bb5\u7684\u968f\u673a\uff081:1\uff09\u90e8\u5206\u7531\u591a\u8fbe58\u540d\u60a3\u8005\u7ec4\u6210\uff0c\u4ed6\u4eec\u5c06\u63a5\u53d730\u6beb\u514befti\u621690\u6beb\u514befti\uff0c\u4ee5\u786e\u5b9a\u4e0e\u7d2b\u6749\u9187\u8054\u5408\u4f7f\u7528\u7684\u6700\u4f73\u751f\u7269\u5242\u91cf\u3002 \u968f\u540e\u53ef\u80fd\u8fdb\u884c\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u7684III\u671f\u6cbb\u7597\uff08\u7b49\u5f85II\u671f\u6cbb\u7597\u7ed3\u679c\uff09\uff0c\u603b\u4f53\u751f\u5b58\u7387\u5c06\u662f\u4e3b\u8981\u76ee\u6807\u3002 Immutep\u4e4b\u524d\u7684efti\u8bd5\u9a8c\u663e\u793a\u4e86\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u7ed3\u679c\uff0c\u5305\u62ec2.9\u4e2a\u6708\u7684\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\uff0c\u4ee5\u53ca\u5728\u9884\u5148\u6307\u5b9a\u7684\u4e9a\u7ec4\u4e2d\uff0c4.2\u81f319.6\u4e2a\u6708\u7684\u663e\u8457\u4e2d\u4f4d\u603b\u751f\u5b58\u671f\u6539\u5584\u3002 \u91cc\u7a0b\u7891\u5f0f\u53d1\u5c55 Immutep\u516c\u53f8\u9996\u5e2d\u79d1\u5b66\u5b98Fr\u00e9d\u00e9ric Triebel\u6559\u6388\u8bf4\uff0c\u7b2c\u4e00\u4e2a\u75c5\u4eba\u7684\u5242\u91cf\u88ab\u8ba4\u4e3a\u662f\u8be5\u516c\u53f8\u7684\u4e00\u4e2a\u91cc\u7a0b\u7891\u5f0f\u7684\u53d1\u5c55\u3002 &#8220;\u4ed6\u8bf4\uff1a&#8221;\u6211\u4eec\u7684\u76ee\u6807\u662f\u6539\u5584\u4e34\u5e8a\u7ed3\u679c\uff0c\u91cd\u70b9\u662f\u5728\u7b2c\u4e09\u9636\u6bb5\u4e3a\u63a5\u53d7\u6807\u51c6\u62a4\u7406\u5316\u7597\u7684\u60a3\u8005\u63d0\u4f9b\u4e00\u4e2a\u5f3a\u6709\u529b\u7684\u4e3b\u8981\u7ec8\u70b9\uff0c\u5373\u603b\u751f\u5b58\u671f\u3002 &#8220;\u6211\u4eec\u671f\u5f85\u7740\u770b\u523090\u6beb\u514b\u7684efti\u5242\u91cf\u4e0e\u540c\u65e5\u7ed9\u836f\u7684efti\u52a0\u7d2b\u6749\u9187\uff0c\u76f4\u5230\u75be\u75c5\u8fdb\u5c55\uff0c\u53ef\u80fd\u4f1a\u5efa\u7acb\u5728\u6211\u4eec\u4ee5\u524d\u7684\u8bd5\u9a8c\u7ed3\u679c\u4e4b\u4e0a\u3002&#8221; \u764c\u75c7\u7684\u6cbb\u7597 Efti\u662fImmutep\u516c\u53f8\u4e13\u6709\u7684\u53ef\u6eb6\u6027LAG-3\u86cb\u767d\u548cMHC II\u7c7b\u6fc0\u52a8\u5242\uff0c\u53ef\u523a\u6fc0\u5148\u5929\u548c\u9002\u5e94\u6027\u514d\u75ab\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u3002 \u4f5c\u4e3a\u4e00\u6d41\u7684\u6297\u539f\u5448\u9012\u7ec6\u80de\uff08APC\uff09\u6fc0\u6d3b\u5242\uff0cEfti\u4e0eMHC\uff08\u4e3b\u8981\u7ec4\u7ec7\u76f8\u5bb9\u6027\u590d\u5408\u4f53\uff09II\u7c7b\u5206\u5b50\u7ed3\u5408\uff0c\u5bfc\u81f4CD8+\u7ec6\u80de\u6bd2\u6027T\u6dcb\u5df4\u7ec6\u80de\u3001CD4+\u8f85\u52a9T\u7ec6\u80de\u3001\u6811\u7a81\u72b6\u7ec6\u80de\u3001\u81ea\u7136\u6740\u4f24\uff08NK\uff09\u7ec6\u80de\u548c\u5355\u6838\u7ec6\u80de\u7684\u6fc0\u6d3b\u548c\u589e\u751f\u3002 \u5b83\u8fd8\u80fd\u4e0a\u8c03\u5173\u952e\u751f\u7269\u5206\u5b50\u7684\u8868\u8fbe\uff0c\u5982IFN-y\uff08\u5e72\u6270\u7d20\u03b3\uff09\u548cCXCL10\uff0c\u8fdb\u4e00\u6b65\u63d0\u9ad8\u514d\u75ab\u7cfb\u7edf\u7684\u6297\u764c\u80fd\u529b\u3002 Efti\u6b63\u88ab\u8bc4\u4f30\u7528\u4e8e\u5404\u79cd\u5b9e\u4f53\u80bf\u7624\uff0c\u5305\u62ec\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u3001\u5934\u9888\u90e8\u9cde\u72b6\u7ec6\u80de\u764c\uff08HNSCC\uff09\u548c\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u3002 \u5b83\u66fe\u5728\u4e00\u7ebfHNSCC\u548c\u4e00\u7ebfNSCLC\u4e2d\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u5feb\u901f\u901a\u9053\u6307\u5b9a\u3002<\/p>\n","protected":false},"author":4,"featured_media":18211,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[303],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-25T01:08:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:58:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Immutep-ASX-IMM-chemotherapy-metastatic-breast-cancer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/\",\"name\":\"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-05-25T01:08:40+00:00\",\"dateModified\":\"2023-08-29T17:58:01+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f","description":"\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f","og_description":"\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/","og_site_name":"smallcapsCN","article_published_time":"2023-05-25T01:08:40+00:00","article_modified_time":"2023-08-29T17:58:01+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Immutep-ASX-IMM-chemotherapy-metastatic-breast-cancer.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/","url":"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/","name":"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-05-25T01:08:40+00:00","dateModified":"2023-08-29T17:58:01+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u751f\u7269\u6280\u672f\u516c\u53f8Immutep (ASX: IMM)\u5728\u6b27\u6d32\u7684\u4e00\u4e2a\u4e34\u5e8a\u57fa\u5730\u4e3a\u5176\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u7efc\u5408II\/III\u671fAIPAC-003\u8bd5\u9a8c\u7684\u7b2c\u4e00\u4f4d\u75c5\u4eba\u5b89\u5168\u5730\u6295\u836f\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/immutep-doses-first-patient-phase-ii-iii-efti-trial-treat-metastatic-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Immutep \u4e3a\u6cbb\u7597\u8f6c\u79fb\u6027\u4e73\u817a\u764c\u7684\u4e8c\/\u4e09\u671f efti \u8bd5\u9a8c\u4e2d\u7684\u9996\u4f8b\u60a3\u8005\u914d\u836f"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6866"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6866"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6866\/revisions"}],"predecessor-version":[{"id":20664,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6866\/revisions\/20664"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18211"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}